Partnerships in Personalized Medicine for In Vitro Diagnostics - Europe

Recognizing the Opportunity in Personalized Medicine Through Partnerships in the Development and Commercialization of Companion Diagnostics

July 27-28
Munich, Germany

This conference program will provide a platform for both diagnostic and therapeutic companies to come together to discuss the challenges and inherent opportunities that exist in partnerships established to enhance personalized medicine and companion diagnostics.Through case studies that highlight
the successes in development, regulatory hurdles and commercialization of these companion tests, to round-table discussions that delve into specific therapeutic areas such as cancer, heart disease and diabetes.

Key Sessions to Note

Creating Commercially Viable Partnerships with IVDs for Personalized Medicine
Peer Schatz

CEO

Qiagen

Balancing Risk, Control and Cost in the Delicate Partnership of Co-Developments
Kari Stefansson
CEO
deCODE genetics

Delivering a Companion Diagnostic for a Targeted Cancer Therapy
Stephen Little PhD
CEO
DxS Ltd.

And Many More...

For the full conference agenda, registration details, and information on promotional pricing please contact:
Paul Hernandez, Marketing Manager
phernandez@Q1productions.com
312-602-9684